<DOC>
	<DOCNO>NCT02986529</DOCNO>
	<brief_summary>To evaluate Bioavailability GV-971 capsule 150 mg , 300mg , 450mg administration single oral dos 900mg healthy Male subject .</brief_summary>
	<brief_title>A Study Assess Bioavailability Oral Sodium Oligo-mannurarate ( GV-971 ) Healthy Chinese Male Subjects</brief_title>
	<detailed_description />
	<criteria>1 . Healthy male subject ; 2 . Age：≥18 ≤45 date signing inform consent 3 . Body mass index ( BMI ) : 1825 kg/m2 weight ≥50 kg； 4 . Subjects able understand study procedure method , willing strictly comply protocol give write informed consent . A subject exclude answer follow criterion `` yes '' : ： 1 . Clinically significant abnormality physical examination laboratory test result 12lead ECG , etc . screening ; 2 . Clinically significant abnormality Chest Xray abdominal Bultrasound examination 3 . Positive serology screen Hepatitis B ( HBsAg ) , Hepatitis C ( HCV ) , HIV USR unheated serum reagin test . 4 . Smoking 10 cigarette day , drug alcohol abuse within 6 month prior screen 5 . Participation investigational drug medical instrument study within 3months prior screening , participation 3 3 drug test recent year ; 6 . Serious infection , trauma major surgery within 4weeks prior screening ; 7 . Blood donation ≥400 mL severe blood lose volume blood loss ≥400 mL within 4 week prior screen , receive blood transfusion treatment within 8 week prior screen ; 8 . Use prescription medicine herbal remedy , counter medication dietary supplement vitamin , calcium within 2 week prior screen . 9 . Use heparin , alginic sodium diester , mannose ester within 4 week prior screening； 10 . Vegetarian person dietary restriction 11 . Subjects able father child unwilling use highly effective physical form birth control trial period 3 month completion study . 12 . With disease could impact absorption , distribution , metabolism excretion ( ADME ) study drug protocol adherence opinion investigator ( medical disorder/disease may relate ccardiovascular , liver , kidney , digestive , immune , blood , endocrine , metabolic , cancer , neuropsychiatric , etc ) ; 13 . Subjects may allergic GV971 opinion investigator . 14 . Any reason subject eligible participation study opinion investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>